BeyondSpring Inc. (NASDAQ: BYSI) stock fell -6.37% on Friday to $2.50 against a previous-day closing price of $2.67. With 0.6 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.98 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.7000 whereas the lowest price it dropped to was $2.3600. The 52-week range on BYSI shows that it touched its highest point at $3.74 and its lowest point at $0.54 during that stretch. It currently has a 1-year price target of $1.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BYSI was up-trending over the past week, with a rise of 20.77%, but this was down by -4.21% over a month. Three-month performance surged to 212.81% while six-month performance rose 71.23%. The stock lost -29.58% in the past year, while it has gained 32.98% so far this year. A look at the trailing 12-month EPS for BYSI yields -1.65 with Next year EPS estimates of -2.49.
Float and Shares Shorts:
At present, 38.93 million BYSI shares are outstanding with a float of 23.14 million shares on hand for trading. On Oct 13, 2022, short shares totaled 2.32 million, which was 5.97% higher than short shares on Sep 14, 2022. In addition to Dr. Lan Huang as the firm’s Co-Founder, Chairman & CEO, Dr. G. Kenneth Lloyd serves as its Chief Scientific Officer.
Through their ownership of 22.93% of BYSI’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 4.98% of BYSI, in contrast to 0.44% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in BYSI with 0.88% of the stake, Millennium Management LLC holds 343,976 shares worth 343,976. A second-largest stockholder of BYSI, BNP Paribas Arbitrage SNC, holds 247,776 shares, controlling over 0.64% of the firm’s shares. Renaissance Technologies LLC is the third largest shareholder in BYSI, holding 170,996 shares or 0.44% stake. With a 0.12% stake in BYSI, the iShares Tr. – Micro Cap ETF is the largest stakeholder. A total of 45,415 shares are owned by the mutual fund manager. The Vanguard Russell 2000 Growth Inde, which owns about 0.09% of BYSI stock, is the second-largest Mutual Fund holder. It holds 35,581 shares valued at 66892.0. Fidelity Nasdaq Composite Index F holds 0.05% of the stake in BYSI, owning 20,183 shares worth 37944.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BYSI since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 1 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With BYSI analysts setting a high price target of $11.00 and a low target of $1.00, the average target price over the next 12 months is $6.00. Based on these targets, BYSI could surge 340.0% to reach the target high and fall by -60.0% to reach the target low. Reaching the average price target will result in a growth of 140.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. BYSI will report FY 2022 earnings on 02/28/2024. Analysts have provided yearly estimates in a range of -$1.38 being high and -$1.38 being low. For BYSI, this leads to a yearly average estimate of -$1.38. Based on analyst estimates, the high estimate for the next quarter is -$0.24 and the low estimate is -$0.24. The average estimate for the next quarter is thus -$0.24.